Viable pathogens capable of triggering permanent disability, life-threatening illness, or fatal disease in otherwise healthy humans or animals fall into this hazard class during transport. The label sits at the top of Division 6.2 in the United Nations Model Regulations on the Transport of Dangerous Goods, governing how the most hazardous biological materials move between laboratories, hospitals, and research facilities.
In practice, the designation triggers triple packaging, specific UN numbers, and a paper trail that can be audited for years.
This editorial covers the official definition, the two-pronged severity and viability test that triggers the label, the UN numbers used to identify each shipment, and the packaging and documentation required to move these materials legally. The intended reader is a clinical lab compliance officer, a dangerous goods shipper, or a safety officer building a defensible classification workflow.
The Regulatory Origins of Dangerous Goods Classification
The United Nations Model Regulations on the Transport of Dangerous Goods created a tiered system to standardize how hazardous materials cross borders, replacing a patchwork of national rules that slowed trade and created safety gaps. Within that system, Division 6.2 covers infectious substances, separating them from chemicals, radioactive material, and explosives because the handling controls differ.
How the UN Tiered System Works
A separate UN number identifies each hazard class and category, letting carriers, customs agents, and emergency responders recognize the contents without opening the package. For infectious substances, two numbers matter most: UN 2814 for materials pathogenic to humans, and UN 2900 for materials pathogenic to animals only. Both the U.S.
Department of Transportation (DOT) and the International Air Transport Association (IATA) adopt these numbers in their own regulations, so a shipment identified as UN 2814 in Berlin is handled the same way in Boston.
Within Division 6.2, two risk-based categories emerged: Category A for the most dangerous pathogens and Category B for everything else that is still regulated. The split lets carriers apply stricter packaging, training, and documentation to the highest-risk materials while keeping routine diagnostic specimens moving efficiently.
The Two-Part Test That Decides Category A Status
A substance earns the Category A label only when both prongs of a strict legal test are met, and missing either prong drops it into a lower tier. You need a clear grasp of this test because the difference between compliant shipping and a costly enforcement action comes down to it.
Prong One: Severity of Disease
The pathogen must be capable of causing permanent disability, a life-threatening illness, or a fatal disease in otherwise healthy humans or animals. This is not a probability test; a single confirmed exposure event leading to severe outcomes is enough. Ebola virus cultures and Bacillus anthracis cultures are textbook Category A examples, both capable of killing a healthy adult even with prompt medical care.
Prong Two: Form and Viability
That be present in a form capable of spreading, meaning viable, cultured, or otherwise able to replicate in a host. A fixed smear on a microscope slide or an inactivated sample no longer meets this standard and falls out of Category A. IATA’s Dangerous Goods Regulations (DGR) and the CDC select agents list provide the reference points shippers use to confirm viability.
The Patient Specimen Exception
Patient specimens that merely contain a Category A pathogen but do not meet both criteria fall under Category B unless they are concentrated cultures. This is the single most common compliance mistake in clinical laboratories, because a swab from an Ebola patient sent for routine confirmation is not the same thing as a cultured stock of Ebola virus. The first is a diagnostic specimen, the second is Category A.
When the Pathogen Is Not Listed
When a pathogen is absent from IATA Table 3.3.D, shippers may apply professional judgment and must document the reasoning behind the call. The CDC, the World Health Organization (WHO), and peer-reviewed risk group classifications provide the evidence base. Your written judgment must be retained and defensible if a regulator reviews the shipment later.
UN 2814 and UN 2900 and the Pathogens They Represent
Two UN numbers carry the entire Category A infectious substance list, and knowing which one applies determines everything that follows, from packaging to paperwork.
UN 2814: Pathogens Affecting Humans
Human-affecting pathogens, including those that also infect animals, are consolidated under UN 2814 for streamlined identification. IATA’s indicative list includes cultures of Ebola virus, Bacillus anthracis, Brucella species, and Yersinia pestis as clear Category A entries. The list is not exhaustive, and any newly characterized pathogen that meets the severity and viability test also falls under UN 2814.
UN 2900: Animal-Only Pathogens
Veterinary shipments pathologically restricted to animals travel under UN 2900, which runs parallel to the human-focused codes. This separation matters because animal pathogens often have different diagnostic pathways, and the receiving laboratory may be an agricultural or veterinary facility rather than a clinical hospital. Mixing the two numbers confuses handlers and can delay a shipment at the dock.
Select Agents Overlap
CDC and USDA select agents intersect substantially with this list, creating a shared compliance zone for high-containment laboratories. A facility that already follows CDC select agent rules is well-positioned to meet IATA Category A requirements, though the two systems cover different activities and are not interchangeable.
| UN Number | Pathogen Scope | Representative Examples |
|---|---|---|
| UN 2814 | Infectious substances affecting humans | Ebola virus, Bacillus anthracis, Brucella abortus, Yersinia pestis |
| UN 2900 | Infectious substances affecting animals only | African swine fever virus, Newcastle disease virus, Foot-and-mouth disease virus |
Knowing the UN number before shipping determines the packaging instruction, the label set, and the documentation chain. Skipping this step is how shipments get rejected at the airline counter.
Misclassifying at this stage means regulators will question every downstream step in the chain.
Where Category A Ends and Category B Begins
Routine clinical specimens default to Category B, and recognizing where that boundary begins keeps testing moving without unnecessary controls.
The Severity Threshold
Category B applies to infectious substances that do not meet the Category A severity test, even when they are capable of causing disease. Most diagnostic specimens fall here: blood drawn for a hepatitis C test, a throat swab sent for strep culture, or a urine sample routed to a reference lab. These materials can cause illness, but the outcomes are typically treatable and not life-threatening in a healthy person exposed during transit.
The Cultures Versus Specimens Distinction
Diagnostic specimens and patient samples sent for routine testing almost always qualify as Category B, not Category A. The dividing line is form: a patient specimen is what comes out of the body, while a culture is what grows in the lab. Concentrated, propagated cultures of pathogens that meet the severity test re-enter Category A territory regardless of the original specimen type.
Side-by-Side Comparison
| Feature | Category A | Category B |
|---|---|---|
| Severity threshold | Permanent disability, life-threatening, or fatal in healthy humans/animals | Does not meet Category A severity |
| Typical form shipped | Cultures and stocks of pathogens | Diagnostic specimens and patient samples |
| UN number | UN 2814 or UN 2900 | UN 3373 |
| Packaging instruction | P620 | P650 |
| Shipper’s Declaration required | Yes | No (but documentation retained) |
Common Misclassification Traps
Misclassifying a culture as a patient specimen is the single most common compliance error in clinical laboratories. The shortcut seems harmless because both involve the same pathogen, but the packaging, labeling, and carrier acceptance steps are entirely different. Regulators treat the misclassification as a violation regardless of intent.
Materials Outside Both Categories
Biological products, medical waste, and genetically modified organisms follow separate rules that can resemble Category A or B without belonging to either category. A vaccine shipment, a sharps container, or a gene therapy vector each has its own regulatory pathway. Assuming one of the two infectious substance categories applies by default can lead to the wrong documentation and a rejected shipment.
Packaging Instruction P620 and the Triple-Pack System
IATA assigns P620 to Category A infectious substances, mandating a tested three-layer system engineered to survive drops, pressure shifts, and handler mistakes.
The Three Layers Explained
P620 packaging requires a leakproof primary receptacle, a leakproof secondary receptacle with absorbent material, and a rigid outer package tested for pressure and drop. The primary receptacle holds the sample itself, typically a sealed tube or vial. The secondary receptacle contains the primary, with enough absorbent material to soak up the entire contents if the primary breaks. The rigid outer protects against physical damage during handling and must pass specific drop and pressure tests documented by the manufacturer.
Labels and Marks
The rigid outer must carry the UN number, the proper shipping name, and the Class 6.2 infectious substance label on a diamond background. The diamond-shaped Class 6.2 label is the visual cue that tells handlers what is inside without requiring them to read every line of the documentation. Overpacks must be marked to repeat the UN number and the phrase “Overpack” so handlers see the contents without opening the box.
Quantity Limits by Aircraft Type
Passenger aircraft cap package quantities more tightly than cargo aircraft, reflecting the heightened safety margins for cabin carriage. A package destined for a passenger flight carries a smaller volume ceiling than the same UN number on a dedicated cargo flight. This is why the Shipper’s Declaration includes aircraft-specific fields and why the carrier will reject a package exceeding the relevant limit.
Why Each Layer Exists
Handlers, couriers, and first responders face the consequences when any layer fails, which is why each component of the triple pack earns its place. A cracked vial inside a sealed bag inside a sturdy box is a contained incident. The same cracked vial in a single padded envelope is an exposure event. P620 testing simulates real-world stresses because the regulations assume something will eventually go wrong.
P620 packaging must be sourced from a UN-certified manufacturer, and the certification mark on the box is the proof. Unmarked or self-assembled packaging is not acceptable for Category A shipments.
Training, Documentation, and Cross-Modal Compliance
Even correctly classified and packaged materials can be rejected if the paperwork or the people handling them are not qualified, and the rules differ across transport modes.
Shipper’s Declaration and Recordkeeping
A Shipper’s Declaration for Dangerous Goods must be completed and retained for at least two years following acceptance. The declaration captures the UN number, the proper shipping name, the hazard class, the packaging instruction used, and emergency contact information. Two years is the IATA minimum, and some carriers or national regulators require longer retention.
Training Requirements
Carriers, freight forwarders, and laboratory personnel must complete IATA-approved recurrent training every two years. Initial training covers classification, packaging, labeling, and emergency response. Recurrent training updates the same content against the latest edition of the IATA DGR, which is revised annually. A person who has not refreshed training within the window cannot sign a Shipper’s Declaration.
Modal Regulation Layers
Air transport follows IATA Dangerous Goods Regulations, while U.S. domestic shipments also fall under DOT 49 CFR and international road transport under ADR. Each modal regulation layers onto the others, so the most stringent applicable rule governs the shipment. A package moving by air and then by truck still meets the air standard throughout its journey, because ground handlers downstream inherit the same package.
The Final Operational Check
Classification, packaging, labels, marks, documentation, and training should each be verified before any Category A package reaches the carrier. Skipping any one of these is the fastest path to a rejected shipment or a regulatory finding. A short checklist taped to the shipping bench catches most errors before the courier arrives.
Bottom Line
Legal determination, not judgment, governs this status, and every shipment clears a two-pronged severity and viability gate before packaging or paperwork begins. Get the classification right, apply P620, complete the Shipper’s Declaration, and the rest of the process follows. Get it wrong, and the consequences land on the shipper, the carrier, and anyone who handles the package along the route.
FAQ
What qualifies as a Category A infectious substance?
A substance qualifies when it is a viable pathogen capable of causing permanent disability, life-threatening illness, or fatal disease in healthy humans or animals. The IATA Table 3.3.D indicative list includes cultures of Ebola, Bacillus anthracis, and Brucella species, and unlisted pathogens can also qualify if both prongs of the test are met.
How do Category A and Category B infectious substances differ?
Category A covers pathogens that meet the high-severity, viability, and form test and requires P620 packaging plus a Shipper’s Declaration. Category B covers diagnostic specimens and patient samples that do not meet the Category A severity threshold and uses UN 3373 with P650 packaging under less stringent documentation.
Which UN numbers are assigned to Category A substances?
UN 2814 covers Category A substances affecting humans, and UN 2900 covers those affecting animals only. Both numbers trigger P620 packaging and Class 6.2 labeling, but they route shipments to different receiving facilities.
What packaging is required for Category A infectious substances?
Category A shipments require P620 packaging, which is a UN-certified triple-pack system: a leakproof primary receptacle, a leakproof secondary receptacle with absorbent material, and a rigid outer package tested for drop and pressure. The outer box must display the UN number, the proper shipping name, and the Class 6.2 diamond label.
Are patient samples considered Category A infectious substances?
Patient samples are not Category A in most cases. They qualify as Category B diagnostic specimens unless the material is a concentrated culture of a pathogen that meets the Category A severity and viability test. Treating a routine swab as Category A is over-classification, while treating a culture as a routine swab is the more dangerous mistake.
Can Category A infectious substances be shipped by air?
IATA Dangerous Goods Regulations permit air shipment of these substances, though passenger aircraft face tighter quantity caps than cargo aircraft. The shipment requires a current Shipper’s Declaration, P620 packaging, and a carrier that accepts dangerous goods on the requested route.
